Search Results
Sep 03, 2026, 04:30 ET AWOL Vision Debuts LuxVision at IFA 2026: World's First 4K 120Hz UST with Optical Shift
here: https://drive.google.com/drive/folders/1JX8CvnjM-3aOpNd2oQ7T7gPwLNZllr1X
More news about: AWOL Vision
Sep 03, 2026, 04:00 ET Laifen Unveils Its Biggest Personal Care Portfolio Yet at IFA 2026
deliver fast, intelligent drying through precision airflow and temperature control, all within a lightweight, compact design.P3, P3 Pro, T1 Pro Electric Shavers: Engineered for a close, comfortable shave with advanced precision technology and an ergonomic designEurope continues
More news about: Laifen
Sep 03, 2026, 01:58 ET Studsvik, GE Vernova Hitachi and Samsung C&T commit to advancing 1.2 GW nuclear power project in Sweden
2026 Following a competitive evaluation process, Studsvik has selected GE Vernova Hitachi Nuclear Energy and Samsung C&T as its strategic partners for the first project to build new nuclear power, either at its existing licensed nuclear site in or at the Målma site in
More news about: Studsvik AB
Sep 03, 2026, 01:31 ET EpiVax ने प्रतिरक्षाजनत्व पूर्वानुमान के लिए AI-संवर्धित मॉडल लॉन्च किए
से कम्प्यूटेशनल इम्यूनोलॉजी में अग्रणी भूमिका निभाई है। इस कार्य के लिए प्रतिरक्षाजनत्व जोखिम और प्रतिरक्षा सहिष्णुता को क्रमवार चिह्नित करने के लिए T सेल एपिटोप सामग्री और मानव क्रॉस-संरक्षण का मूल्यांकन करने वाले EpiMatrix® और JanusMatrix™ मौलिक हैं। ISPRI™ इन उपकरणों को अन्य व्यापक रूप
More news about: EpiVax, Inc.
Sep 03, 2026, 01:22 ET EpiVax führt KI-gestützte Modelle zur Vorhersage der Immunogenität ein
In-silico-Algorithmen für die Bewertung biotherapeutischer Sequenzen. Grundlage dieser Arbeit sind EpiMatrix® und JanusMatrix™, die den Gehalt an T-Zell-Epitopen und die konservierung über verschiedene menschliche Arten hinweg bewerten, um das aus der Sequenz abgeleitete Immunogenitätsrisiko und die
More news about: EpiVax, Inc.
Sep 03, 2026, 01:20 ET EpiVax lance des modèles optimisés par l'IA pour la prédiction de l'immunogénicité
biothérapeutiques. Ce travail s'appuie sur les technologies EpiMatrix® et JanusMatrix™, qui évaluent la composition en épitopes des lymphocytes T et la conservation croisée chez l'humain afin de caractériser le risque d'immunogénicité lié à la séquence et la tolérance immunitaire. ISPRI™ associe
More news about: EpiVax, Inc.
Sep 02, 2026, 22:51 ET CGTN : comment l'OCS ouvre la voie à de nouvelles perspectives de développement régional à l'occasion de son 25e anniversaire
les pays d'Eurasie, tandis que l'initiative pour le développement mondial a favorisé la croissance économique et amélioré les conditions de vie », a-t-il déclaré, ajoutant que ces initiatives s'inscrivent parfaitement dans les priorités de développement des membres de l'OCS, créant ainsi des opportunités
More news about: CGTN
Sep 02, 2026, 21:17 ET DSC® 發表 MORPH 多元材料整合平台 打造高性能泡棉與多功能複合材料新應用
www.dahsheng.com 獲取詳盡資訊。媒體聯繫人：Erin Pattersont: +1-323-422-0274e: [email protected]
More news about: Dahsheng Company
Sep 02, 2026, 18:35 ET /C O R R E C T I O N -- Authentic Brands Group/
More news about: Authentic Brands Group
Sep 02, 2026, 17:38 ET World's Largest Indoor, Multi-Level Karting Track & Premier Entertainment Venue Celebrates Groundbreaking in Columbus, Ohio
/C O R R E C T I O N – Supercharged Entertainment/ In the news release, World's Largest Indoor, Multi-Level Karting Track & Premier Entertainment Venue Celebrates Groundbreaking in Columbus, Ohio, issued Sept. 2, 2026 by Supercharged Entertainment over PR Newswire, we are advised by the company
More news about: Supercharged Entertainment
Sep 02, 2026, 17:00 ET Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC
anchored by its proprietary Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform, Tissue-Smart siRNA/mRNA technology platform, and cell therapy technology platforms.Backed by world-class
More news about: Akeso, Inc.
Sep 02, 2026, 16:34 ET /C O R R E C T I O N -- Vale Matcha/
/C O R R E C T I O N – Vale Matcha/ In the news release, Vale Matcha Announces Vale Farms, With Plans to Grow One Million Tea Plants on Whidbey Island, issued 31-Aug-2026 by Vale Matcha over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release
More news about: Vale Matcha
Sep 02, 2026, 12:49 ET Simcere Zaiming signe un accord de licence exclusif avec Roche pour le développement mondial du SIM0660
d'anticorps polyspécifiques engageant les lymphocytes T. Cette molécule associe un bras d'engagement CD3 à des domaines de liaison ciblant les deux antigènes des lymphocytes B, le CD79a et le CD19, afin d'induire une cytotoxicité puissante à médiation lymphocytaire T tout en limitant la libération de cytokines.
More news about: Simcere
Sep 02, 2026, 12:17 ET DSC® Unveils MORPH Adaptable Materials Platform and Advanced Foam Construction
DSC® and its commitment to sustainability and eco-innovation.Media Contact:Erin Pattersont: +1-323-422-0274e: [email protected]
More news about: Dahsheng Company
Sep 02, 2026, 12:00 ET Airbility Secures KRW 6.5 Billion Series A Led by Sazze Partners, Bringing Total Funding to USD 7.6 million
software.Built for Speed, Affordability and ExportabilityAirbility was co-founded in November 2023 by researchers who helped develop Korea's KT-1, T-50 and KF-21 aircraft at the Agency for Defense Development, together with professionals from Hyundai Motor, the MIT Media Lab, LG Electronics and Genesis
More news about: Airbility
Sep 02, 2026, 11:26 ET TECNO Will Bring Next-Gen Bezelless Concept Phone and 360° Hinge MEGABOOK T15 360 Pro to IFA ShowStoppers 2026
viewing experience.360° Hinge MEGABOOK T15 360 Pro and Two More New MEGABOOKsThe showcase also features three new MEGABOOK laptops: MEGABOOK T15 360 Pro, MEGABOOK K15S WCL and MEGABOOK T17 Ultra, showcasing TECNO's diverse configuration lineup and breakthrough
More news about: TECNO
Sep 02, 2026, 11:16 ET EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
advanced in silico algorithms for evaluating biotherapeutic sequences. Foundational to this work are EpiMatrix® and JanusMatrix™, which evaluate T cell epitope content and human cross-conservation to characterize sequence-derived immunogenicity risk and immune tolerance. ISPRI™ brings these tools
More news about: EpiVax, Inc.
Sep 02, 2026, 11:04 ET EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
advanced in silico algorithms for evaluating biotherapeutic sequences. Foundational to this work are EpiMatrix® and JanusMatrix™, which evaluate T cell epitope content and human cross-conservation to characterize sequence-derived immunogenicity risk and immune tolerance. ISPRI™ brings these tools
More news about: EpiVax, Inc.
Sep 02, 2026, 10:11 ET EQPT Shareholder Alert: EquipmentShare.com Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
disclosures failed to fully describe related-party dealings involving founder-affiliated entities, including transactions tied to the OWN Program and T3 platform.The Named Individual DefendantsAccording to the complaint, Jabbok Schlacks signed or authorized the signing of the IPO
More news about: Levi & Korsinsky, LLP
Sep 02, 2026, 10:05 ET Tapstitch Takes Fashion-on-Demand to ComplexCon After Successful UNFAZED Atlanta Streetwear Activation
gives clothing brands, creators and entrepreneurs access to:1,000+ premium print-on-demand apparel styles, including heavyweight T-shirts, hoodies, denim, sportswear, streetwear and fashion-forward silhouettesNo minimum order quantity (MOQ), allowing brands to launch and
More news about: Tapstitch
